article thumbnail

Genomics England will move HQ to Canary Wharf’s new biocluster

pharmaphorum

Canary Wharf’s bid to become a new hub for the life sciences sector in the UK has been given a boost following the decision by Genomics England to relocate to the development. facility dedicated to a combination of wet lab and office space, revealed in March, intended as a focal point for life sciences companies in London.

Genome 109
article thumbnail

Bayer delivers on medical innovation fueling transformation of pharma business

The Pharma Data

Re-imagining Radiology. Tackling this challenge with advanced technologies and products, radiology is a key enabler to transform healthcare, expanding personalized medicine and improving outcomes for patients. In particular, AI bears vast potential for advancing radiology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Four ways Biogen is tackling digital innovation in neurological disease

pharmaphorum

It can mean everything from patient-facing disease management apps and wearables to background AI dramatically altering drug discovery or radiological imaging. AI gets us closer to personalised medicine.”. I believe the life sciences industry ecosystem is getting to be more familiar with digital health overall as a concept.

article thumbnail

World Cancer Day 2024: Trends in Oncology Research and More

XTalks

Personalized medicine: One of the most exciting prospects of CRISPR/Cas9 in oncology is its contribution to personalized medicine. For example, a study published in Nature Medicine in 2020 reported on the safety and feasibility of using CRISPR-edited T cells in patients with refractory non-small-cell lung cancer (NSCLC).

Research 118
article thumbnail

Unique ADHD Biomarkers Revealed from MRI Data from the Adolescent Brain Cognitive Development Study

XTalks

Last week , researchers at the Yale School of Medicine reported that they have identified brain biomarkers of attention-deficit/hyperactivity disorder (ADHD) in children. The study results will be presented at the Radiological Society of North America annual meeting , which is currently being held in Chicago, IL until December 1, 2022.

article thumbnail

Rezzayo (Rezafungin) Becomes First New Treatment Option for Candidemia and Invasive Candidiasis in Over a Decade

XTalks

The primary endpoints were global cure (consisting of clinical cure, radiological cure and mycological eradication) at 14 days for the European Medical Agency (EMA), and a 30-day all-cause mortality for the US FDA. Rezafungin met the endpoints outlined by both the EMA and FDA.

article thumbnail

What will the 2023 drug discovery landscape look like?

Drug Discovery World

But Jeffrey Petrella, Professor of Radiology and Director of the Alzheimer Imaging Research Laboratory at Duke University School of Medicine, says: “Despite these limitations, this is the first step towards tailored clinical trials. We’ve shown that this type of model can work.